UPDATE : Tuesday, August 11, 2020
상단여백
Hanmi, GC to co-develop rare diseases treatments by Lee Han-soo 2020-02-27 16:50
JW Shinyak launches new hand eczema treatment by Lee Han-soo 2020-02-27 16:50
FDA OKs 2 phase-3 clinical trials for Gilead's Remdesivir by Shim Hyun-tai 2020-02-27 16:08
Alvogen Korea wins anti-bribery system certification by Lee Han-soo 2020-02-27 12:10
Huons Global posts ₩449.4 billion in 2019 sales by Lee Han-soo 2020-02-26 16:15
라인
US begins to test remdesivir for COVID-19 treatment by Kim Yun-mi 2020-02-26 15:21
Novo Nordisk’s Saxenda remains at top in obesity treatment sales by Shim Hyun-tai 2020-02-25 18:12
Will Korean COVID-19 patients get to use remdesivir for compassionate use? by Kim Yun-mi 2020-02-24 17:41
Local researchers find new cause of Parkinson’s disease by Shim Hyun-tai 2020-02-21 18:25
Labor group slams Fresenius for allegedly breaching labor law by Kim Yun-mi 2020-02-21 16:39
라인
‘Favipiravir not approved as new coronavirus drug yet’ by Kim Yun-mi 2020-02-21 12:08
Theragen Etex marked record-high sales, net profits in 2019 by Lee Han-soo 2020-02-20 18:48
Regulator OKs Pfizer's Vizimpro as 1st-line treatment of mutated lung cancer by Shim Hyun-tai 2020-02-20 18:47
Daewoong’s Nabota gets item license in Brazil by Shim Hyun-tai 2020-02-20 16:11
Drugmakers rush to roll out famotidine to replace ranitidine by Jeong Sae-im 2020-02-18 15:07
라인
Medytox's Meditoxin gets new indication for cervical dystonia by Shim Hyun-tai 2020-02-18 15:06
JW wins US patent for world’s 1st multi-biomarker diagnostic kit by Shim Hyun-tai 2020-02-17 17:54
Genexine’s US affiliate gets FDA nod for immune booster trial by Shim Hyun-tai 2020-02-17 12:46
Helixmith gets mixed results from p3-1 trials of gene therapy by Shim Hyun-tai 2020-02-14 18:12
Eisai to pull out antiobesity drug Belviq from US market by Lee Han-soo 2020-02-14 16:38
여백
여백
여백
Back to Top